Skip to main content

Computational studies of enzymatic reactions

IJCI-2016-27503

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal de Promoción del Talento y su Empleabilidad en I+D+i
Subprogram Subprograma Estatal de Incorporación
Call Juan de la Cierva Incorporación
Call year 2016
State Plan 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre UNIVERSITAT JAUME I DE CASTELLO

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

A Molecular Modeling Approach to Identify Novel Inhibitors of the Major Facilitator Superfamily of Efflux Pump Transporters

  • Zárate, Sandra G.
  • Morales, Paula
  • Świderek, Katarzyna
  • Bolanos-Garcia, Victor M.
  • Bastida, Agatha
Multidrug efflux systems play a prominent role in medicine, as they are important contributors to bacterial antibiotic resistance. NorA is an efflux pump transporter from the major facilitator superfamily that expels numerous drug compounds across the inner membrane of <i>Staphylococcus aureus</i> (<i>S. aureus</i>). The design of novel inhibitors to combat drug efflux could offer new opportunities to avoid the problem of antibiotic resistance. In this study, we performed molecular modeling studies in an effort to discover novel NorA efflux pump inhibitors. A group of over 673 compounds from the PubChem database with a high (>80%) level of similarity to the chemical structure of capsaicin was used to study the binding affinity of small molecule compounds for the NorA efflux pump. Ten potential lead compounds displayed a good druggability profile, with one in particular (CID 44330438) providing new insight into the molecular mechanism of the inhibition of major facilitator superfamily (MFS) efflux pump transporters. It is our hope that the overall strategy described in this study, and the structural information of the potential novel inhibitors thus identified, will stimulate others to pursue the development of better drugs to tackle multidrug resistance in <i>S. aureus</i>., This research was funded by Ministerio de Economia Industria y Competitividad, grant numbers “CTQ2016-79255-P”and “COOPB20237”. K.S. would like to specially thank the MINECO for a Juan de la Cierva (ref. IJCI-2016-27503) contract. PM would like to thank the Spanish MCIU for her “Juan-de-la-Cierva” post-doctoral fellowship FJCI-2016-29227., We acknowledge support by the CSIC Open Access Publication Initiative through its Unit of Information Resources for Research (URICI), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Exploring the Origin of Amidase Substrate Promiscuity in CALB by a Computational Approach

  • Galmés, Miquel A.
  • García-Junceda, Eduardo
  • Świderek, Katarzyna
  • Moliner, Vicent
Enzyme promiscuity attracts the interest of the industrial and academic sectors because of its application in the design of biocatalysts. The amidase activity of Candida antarctica lipase B (CALB) on two different substrates has been studied by theoretical quantum mechanics/molecular mechanics methods, supported by experimental kinetic measurements. The aim of the study is to understand the substrate promiscuity of CALB in this secondary reaction and the origin of its promiscuous catalytic activity. The computational results predict activation free energies in very good agreement with the kinetic data and confirm that the activity of CALB as an amidase, despite depending on the features of the amide substrate, is dictated by the electrostatic effects of the protein. The protein polarizes and activates the substrate as well as stabilizes the transition state, thus enhancing the rate constant. Our results can provide guides for future designs of biocatalysts based on electrostatic arguments., This work was supported by the Spanish Ministerio de Ciencia, Innovación y Universidades (Grant PGC2018-094852-B-C21), the Spanish Ministerio de Economía y Competitividad (Grant MAT2015-65184-C2-2-R), Universitat Jaume I (project UJI·B2017- 31), and the National Institutes of Health (Ref no. NIH R01 GM065368). K.Ś. thanks the MINECO for a Juan de la Cierva—Incorporación (ref IJCI-2016-27503) contract. M.À.G. thanks Universitat Jaume I for a doctoral FPI grant (PREDOC/2017/23)., Peer reviewed